Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | REN | P00797 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | METAP2 | P50579 | 1/20 | 0.31 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.31 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23949224 | 1.00 | TSHR (0.34) | TSHRRENALDH1A1MAPTHTT | |
| SCHEMBL23925287 | 0.89 | ITGB3 (0.36) | TSHRRENMETAP2ADAMTS5 | |
| SCHEMBL23925288 | 0.89 | ITGB3 (0.36) | TSHRRENMETAP2ADAMTS5 | |
| SCHEMBL23949222 | 0.72 | SMN1; SMN2 (0.38) | ALDH1A1METAP2ADAMTS5GAA | |
| SCHEMBL23948594 | 0.71 | OPRM1 (0.37) | TSHRMETAP2ADAMTS5MEN1GAA | |
| SCHEMBL24804103 | 0.68 | CA1 (0.32) | TSHRMEN1GAAKMT2A | |
| SCHEMBL24804100 | 0.68 | CA1 (0.32) | TSHRMEN1GAAKMT2A | |
| SCHEMBL24471394 | 0.67 | CACNA1H (0.31) | ALDH1A1HTT | |
| SCHEMBL24471393 | 0.67 | CACNA1H (0.31) | ALDH1A1HTT | |
| SCHEMBL30291841 | 0.64 | KMT2A (0.37) | ALDH1A1MAPTHTTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12389910-B2 | Beta-lactams and their use as herbicides | BASF SE (DE) | 2025-08-19 | — | — | US | disclosed |
| EP-4136071-B1 | BETA-LACTAMS AND THEIR USE AS HERBICIDES | BASF SE (DE) | 2024-11-06 | — | — | EP | disclosed |
| US-20230148598-A1 | BETA-LACTAMS AND THEIR USE AS HERBICIDES | BASF SE (DE) | 2023-05-18 | — | — | US | disclosed |
| US-20230148598-A1 | BETA-LACTAMS AND THEIR USE AS HERBICIDES | BASF SE (DE) | 2023-05-18 | — | — | US | disclosed |
| US-20230148598-A1 | BETA-LACTAMS AND THEIR USE AS HERBICIDES | BASF SE (DE) | 2023-05-18 | — | — | US | disclosed |
| EP-4136071-A1 | BETA-LACTAMS AND THEIR USE AS HERBICIDES | BASF SE (DE) | 2023-02-22 | — | — | EP | disclosed |
| WO-2021209268-A1 | BETA-LACTAMS AND THEIR USE AS HERBICIDES | BASF SE (DE) | 2021-10-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230148598-A1 | BETA-LACTAMS AND THEIR USE AS HERBICIDES | POLL, HDHD5, GLRB | TSHR 2808/4885REN 307/4885ALDH1A1 753/4885 |
| US-12389910-B2 | Beta-lactams and their use as herbicides | POLL, HDHD5, GLRB | TSHR 2808/4885REN 307/4885ALDH1A1 753/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.